Coherus Oncology Inc. (chrs 1.5 04/15/26)
13F holders, Q3 2024 (September 30)2holders −1
0new positions
1sold out
$0.78avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Coherus Oncology Inc. (chrs 1.5 04/15/26) in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holders were Jane Street Group, LLC ($2.3M) and Avantax Advisory Services, Inc. ($8K).
- Company
- Coherus Oncology Inc. (chrs 1.5 04/15/26)
- CUSIP
- 19249HAB9
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $4K |
All 13F filers, Q2 2024 → Q3 2024: 6,000 shares sold, net −6,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Jane Street Group, LLC | 0.00% | No change | 3,000,000 | $2.3M |
| Avantax Advisory Services, Inc. | 0.00% | No change | 10,000 | $8K |
"% of holder's portfolio" is COHERUS ONCOLOGY INC (CHRS 1.5 04/15/26)'s weight in each manager's 13F, not the share of Coherus Oncology Inc. (chrs 1.5 04/15/26) the manager owns.